Evidence map›Paper›PMID 38260037›Full record

ArticleJournal of neuroendovascular therapy2023

A Case of Dural Arteriovenous Fistula Following Cerebral Venous Sinus Thrombosis Associated with the COVID-19 Vaccine.

Jiro Aoyama, Hiroto Iha, Mariko Ishikawa, Hirotaka Sagawa, Sakyo Hirai, Kyohei Fujita, Shoko Fujii, Kazutaka Sumita

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuroendovascular therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jiro AoyamaDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Hiroto IhaDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Mariko IshikawaDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Hirotaka SagawaDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Sakyo HiraiDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Kyohei FujitaDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Shoko FujiiDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Kazutaka SumitaDepartment of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Tokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Cerebral venous sinus thrombosis (CVST) is one of the rare and severe complications of coronavirus disease 2019 (COVID-19) vaccines. CVST has also been reported to develop into dural arteriovenous fistula; however, there were no reports of dural arteriovenous fistula associated with COVID-19 vaccine-induced cerebral venous sinus thrombosis. Here, we describe a rare case of a transverse-sigmoid sinus dural arteriovenous fistula followed by CVST due to COVID-19 vaccination. Case Presentation: A 70-year-old patient presented with headache five days after receiving a second dose of COVID-19 vaccine. MRI showed a CVST in the superior sagittal sinus, left transverse sinus, and left sigmoid sinus. His headache improved after the administration of anticoagulant therapy. Six months later, a similar headache recurred, and cerebral angiography demonstrated a dural arteriovenous fistula in the left transverse sigmoid sinus and convexity dural arteriovenous fistulas in the left parietal cortex. The patient was treated twice with two sessions of transarterial embolization, and the shunts were completely occluded. His symptoms improved, and he was discharged with a modified Rankin Scale score of 0. Conclusion: Dural arteriovenous fistula can develop after CVST in association with COVID-19 vaccination.

Indexed as

cerebral venous sinus thrombosisCOVID-19dural arteriovenous fistulavaccine

Identifiers

PMID38260037
PMCPMC10800167
OpenAlexW4388758466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.